Detalles de la búsqueda
1.
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
Br J Dermatol
; 187(3): 338-352, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484697
2.
Tralokinumab improves clinical scores in adolescents with severe atopic dermatitis: A real-life multicentric observational study.
J Eur Acad Dermatol Venereol
; 38(3): e288-e290, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37909058
3.
Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial.
Lancet
; 390(10089): 40-49, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28478975
4.
Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data.
Dermatol Ther (Heidelb)
; 13(11): 2869-2877, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37717224
5.
Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults.
Adv Ther
; 40(5): 2509-2514, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36944819
6.
Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study.
Clin Drug Investig
; 43(4): 299-306, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012527
7.
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials.
Am J Clin Dermatol
; 24(5): 821-835, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37341961
8.
Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study.
Adv Ther
; 39(2): 1068-1080, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34977985
9.
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study.
Adv Ther
; 37(6): 2865-2883, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32378070
10.
Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.
J Am Acad Dermatol
; 70(6): 1146-9, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24831323
11.
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
J Am Acad Dermatol
; 58(1): 25-32, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17919772
12.
Prolonged real-life experience with baricitinib in patients with moderate-to-severe atopic dermatitis.
Eur J Dermatol
; 33(6): 707-709, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38465563
13.
Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study.
Adv Ther
; 40(7): 3279-3280, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246202
14.
Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).
J Dermatolog Treat
; 28(5): 394-400, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27791446
15.
An observational study of the real-life management of psoriasis patients treated with etanercept according to the new reimbursement criteria (in Belgium).
J Dermatolog Treat
; 27(2): 103-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26218849
16.
Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective.
J Dermatolog Treat
; 27(2): 128-33, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26415615
17.
Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study.
JAAD Int
; 4: 15-17, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34409384
18.
Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
Dermatol Online J
; 8(1): 5, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12165215
19.
Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).
Ann Dermatol
; 25(1): 28-35, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23467644
20.
Itchy papules of the axillae.
Arch Dermatol
; 138(2): 259-64, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11843652